Diffusion pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Diffusion pharmaceuticals Contact Number

Diffusion Pharmaceuticals Crunchbase Company Profile

5 hours ago Crunchbase.com Show details

Contact Email [email protected] Phone Number 4342200722. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, TSC, is being developed to enhance the diffusion of

Founded: 2001
Founders: John L. Gainer, David Kalergis

Category: Contact NumberShow more

Home Page Diffusion Pharmaceuticals Inc.

2 hours ago Diffusionpharma.com Show details

Diffusion’s Chief Medical Officer Dr. Chris Galloway provides an overview of the ILD-DLCO Trial, the third in a trio of Oxygenation Trials that will inform late-phase programs and clinical indications for lead drug candidate TSC. October 15, 2021. Episode 3: Evaluating the Effects of TSC on Maximal Oxygen Consumption.

Estimated Reading Time: 4 mins

Category: Home PhoneShow more

Diffusion Pharmaceuticals LLC Company Profile

3 hours ago Dnb.com Show details

(434) 220-0718Company Description: Diffusion Pharmaceuticals LLC is located in Charlottesville, VA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Diffusion Pharmaceuticals LLC has 10 total employees across all of its locations and generates $2.30 million in sales (USD).

Employees: 10
Phone: (434) 220-0718
Location: 1317 Carlton Ave Ste 400, Charlottesville, 22902-6193, VA

Category: Contact NumberShow more

Diffusion Pharmaceuticals Overview, News & …

5 hours ago Zoominfo.com Show details

(434) 220-0718View contact profiles from Diffusion Pharmaceuticals. SIC Code 28,283. NAICS Code 325413,3254. Ticker NASDAQ: DFFN. Show More. Popular Searches: diffusion pharmaceuticals inc. What is Diffusion Pharmaceuticals’s phone number? Diffusion Pharmaceuticals’s phone number is (434) 220-0718.

Employees: 25
Phone: (434) 220-0718
Location: 1317 Carlton Ave, Ste 200, Charlottesville, 22902, Virginia

Category: Contact NumberShow more

Diffusion Pharmaceuticals 2020 Avon Ct Ste 4

4 hours ago Yellowpages.com Show details

(434) 220-0718Get reviews, hours, directions, coupons and more for Diffusion Pharmaceuticals at 2020 Avon Ct Ste 4, Charlottesville, VA 22902. Search for other Medical Equipment & Supplies in Charlottesville on The Real Yellow Pages®.

Location: 2020 Avon Ct Ste 4, Charlottesville, 22902, VA
Phone: (434) 220-0718

Category: Contact NumberShow more

Diffusion Pharmaceuticals CvilleBioHub

1 hours ago Cvillebiohub.org Show details

Diffusion Pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. The company is developing its lead drug, trans sodium crocetinate (TSC), which has received Orphan Drug Designation from

Category: Contact NumberShow more

Our Company Diffusion Pharmaceuticals Inc.

4 hours ago Diffusionpharma.com Show details

Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Oxygen is essential. for life. The constant uptake and delivery of oxygen within our body is necessary to sustain life in sickness and in health, under

Category: Contact NumberShow more

TSC Diffusion Pharmaceuticals Inc.

6 hours ago Diffusionpharma.com Show details

TSC effectively facilitates oxygen movement through the blood plasma, enhancing the rate of oxygen diffusion into hypoxic tissues. The novel mechanism of action improves passive oxygen diffusion from areas of high concentration to areas of low concentration by increasing hydrogen bonding and enhancing the organization of water molecules in blood plasma.

Category: Contact NumberShow more

Our Team Diffusion Pharmaceuticals Inc.

1 hours ago Diffusionpharma.com Show details

Read more. Dr. Galloway joins Diffusion from La Jolla Pharmaceuticals, where he has served as senior medical director – medical affairs in critical care since August 2018. Among his duties at La Jolla, he chaired and oversaw investigator-initiated and collaborative research programs. Prior to La Jolla, he was medical director for global

Category: Contact NumberShow more

Investors Diffusion Pharmaceuticals Inc.

2 hours ago Diffusionpharma.com Show details

Diffusion Pharmaceuticals Inc. 300 East Main Street, Suite 201 Charlottesville, Virginia 22902

Category: Contact NumberShow more

Diffusio2n Trademark Diffusion Pharmaceuticals Llc

1 hours ago Bizapedia.com Show details

Diffusio2n is a Trademark by Diffusion Pharmaceuticals LLC, the address on file for this trademark is 2020 Avon Court, #4, Charlottesville, VA 22902

Category: Contact NumberShow more

Diffusion Pharmaceuticals LinkedIn

8 hours ago Linkedin.com Show details

Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most

Category: Contact NumberShow more

Diffusion Pharmaceuticals Inc. :: Acorn Management

2 hours ago Acornmanagementpartners.com Show details

Dec 20 2021 Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022” Dec 16 2021 Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial; Dec 1 2021 Diffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523

Category: Contact NumberShow more

Diffusion Pharmaceuticals Doses First Participants in

9 hours ago Ca.finance.yahoo.com Show details

Second of Three TSC Oxygenation TrialsCHARLOTTESVILLE, Va., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced it has …

Category: Contact NumberShow more

Fueling Life Trademark Diffusion Pharmaceuticals Llc

3 hours ago Bizapedia.com Show details

Diffusion Pharmaceuticals LLC. Limited Liability Company. Owner At Registration. Virginia · United States. 1317 Carlton Avenue, Suite 200. Charlottesville, VA 22902. Diffusion Pharmaceuticals LLC. Limited Liability Company. Owner at Publication.

Category: Contact NumberShow more

Diffusion Pharmaceuticals Doses First Patients in ILDDLCO

2 hours ago Finance.yahoo.com Show details

CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies

1. Author: Diffusion Pharmaceuticals Inc.

Category: Contact NumberShow more

Numerical investigation of ibuprofen removal from

Just Now Nature.com Show details

598-021-0418A number of simulation has been performed in packed bed scale 21,22. Reynolds mass flux model was used for the simulation of methylene chloride adsorption on activated carbon in a packed column.

Category: Contact NumberShow more

Diffusion Pharmaceuticals Inc. (Form: 8K, Received: 12/13

Just Now Content.edgar-online.com Show details

749-19-0244Item 1.01. Entry Into a Material Definitive Agreement. On December 11, 2019, Diffusion Pharmaceuticals Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (each, a “Purchaser” and together, the “Purchasers”) providing for the sale by the …

Category: Contact NumberShow more

Diffusion Pharmaceuticals to Present at H.C. Wainwright

3 hours ago Finance.yahoo.com Show details

CHARLOTTESVILLE, Va., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies

Category: Contact NumberShow more

Diffusion Pharmaceuticals Doses First Participants in

6 hours ago Finance.yahoo.com Show details

Second of Three TSC Oxygenation TrialsCHARLOTTESVILLE, Va., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a

Category: Contact NumberShow more

Is Diffusion Pharmaceuticals Inc (DFFN) a Smart Choice in

Just Now Investorsobserver.com Show details

Diffusion Pharmaceuticals Inc is near the top in its industry group according to InvestorsObserver.DFFN gets an overall rating of 55. That means it scores higher than 55 percent of stocks. Diffusion Pharmaceuticals Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 85 out of 148 industries.

Category: Contact NumberShow more

Diffusion Pharmaceuticals Inc. (Form: S1/A, Received: 11

Just Now Content.edgar-online.com Show details

749-19-0221Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan* Incorporated by reference to Exhibit 10.2 to the registrant’s current report on Form 8-K as filed on June 18, 2015 10.4 Amendment No. 1 to Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan*

Category: Contact NumberShow more

DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial

8 hours ago Marketscreener.com Show details

Item 8.01 Other Events. On December 16, 2021, Diffusion Pharmaceuticals Inc. (the "Company") issued a press release announcing the dosing of the first patients in its ILD-DLCO Trial evaluating the Company's lead product candidate, trans sodium crocetinate, in patients with previously diagnosed interstitial lung disease A copy of the press release is …

Category: Contact NumberShow more

Information Free FullText Information Diffusion Model

8 hours ago Mdpi.com Show details

Information diffusion, information spread, and influencers are important concepts in many studies on social media, especially Twitter analytics. However, literature overviews on the information diffusion of Twitter analytics are sparse, especially on the use of continuous time Markov chain (CTMC). This paper examines the following topics: (1) the purposes of studies …

Category: Contact NumberShow more

Delisting/Failure to Satisfy Listing Rule/Transfer of

3 hours ago Marketscreener.com Show details

As previously disclosed, on May 6, 2021, Diffusion Pharmaceuticals Inc. (the "Company") received a written notice (the "May Notice") from the staff (the "Staff") of the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") relating to the minimum bid price requirement contained in Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").

Category: Contact NumberShow more

Zacks Small Cap Research DFFN: TSC to be Developed for

2 hours ago Scr.zacks.com Show details

Business Update. On November 10, 2021, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced that the company is intending to develop its lead drug candidate, trans sodium crocetinate (TSC), for the treatment of hypoxic solid tumors. This is based on an increased understanding of the drug’s mechanism of action from the TCOM and COVID-19

Category: Contact NumberShow more

10 Biotech Penny Stocks to Buy Now

3 hours ago Finance.yahoo.com Show details

Number of Hedge Fund Holders: 2 Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) is a biopharma firm that focuses on the development of novel therapies for enhanced delivery of oxygen through the body.

Category: Tech SupportShow more

4 Reasons Why Ocugen Will Make Very Little or No Money

9 hours ago Msn.com Show details

12.29.235

1. Another one of the bulls’ recent theories is that an approval of Covaxin by the World Health Organization (WHO) will lead to the FDA giving Covaxin a thumbs up. As others have pointed out, the FDA is not obligated to fall in line with WHO’s decisions. Indeed, WHO has long ago approved multiple vaccines for the coronavirus—including jabs developed by AstraZeneca (NASDAQ:AZN) and China’s Sinovac—that the FDA has not come close to approving.

Category: Contact NumberShow more

DFFN Diffusion Pharmaceuticals Inc — Stock Price and

4 hours ago Stocktwits.com Show details

Diffusion Pharmaceuticals Inc NASDAQ Updated Jan 13, 2022 3:23 PM. DFFN 0.29 0.00 (0.72%). 22,885

Category: Contact NumberShow more

DIFFUSION PHARMACEUTICALS INC. : DFFN Stock Price

8 hours ago Marketscreener.com Show details

Diffusion Pharmaceuticals Inc. is a biopharmaceutical company. The Company is engaged in the development of therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed. The Company’s product candidate includes Trans Sodium Crocetinate (TSC) and DFN-529.

Category: Contact NumberShow more

Diffusion Pharmaceuticals Inc. BIOEurope

6 hours ago Informaconnect.com Show details

BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.

Category: Contact NumberShow more

Global Glioblastoma Multiforme (GBM) Industry Landscape,

9 hours ago Globenewswire.com Show details

917-300-0470Contact Data CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For

Category: Contact NumberShow more

Diffusion Pharmaceuticals Stock Forecast, Price & News

6 hours ago Marketbeat.com Show details

434-220-0718

1. Diffusion Pharmaceuticals' mailing address is 1317 CARLTON AVENUE SUITE 200, CHARLOTTESVILLE VA, 22902. The company can be reached via phone at 434-220-0718 or via email at [email protected]

Category: Contact NumberShow more

What is Diffusion Pharmaceuticals Valuation? DFFN Macroaxis

6 hours ago Macroaxis.com Show details

What is the current enterprise value of Diffusion Pharmaceuticals? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Diffusion Pharmaceuticals, is its stock price multiplied by the total number of shares outstanding, calculating Diffusion Pharmaceuticals' enterprise value requires a different …

Category: Contact NumberShow more

Global Glioblastoma Multiforme (GBM) Industry Landscape

9 hours ago Finance.yahoo.com Show details

917-300-0470CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT

Category: Contact NumberShow more

Diffusion Pharmaceuticals Inc. Share Price Trade now

2 hours ago Capital.com Show details

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body''s ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease.

Category: Contact NumberShow more

What Do Analysts Think Will Happen To Diffusion

8 hours ago Stocksregister.com Show details

The number of analysts that have assigned DFFN a recommendation rating is 1. Out of them, 1 rate it a Hold, while 0 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Diffusion Pharmaceuticals Inc. (DFFN) as …

Category: Contact NumberShow more

ex_203251.htm

Just Now Sec.gov Show details

Exhibit 10.2 . EMPLOYMENT AGREEMENT . This Employment Agreement (this “Agreement”) is entered into as of September 8, 2020 (the “Effective Date”) by and between Diffusion Pharmaceuticals Inc. (the “Company”) and Robert J. Cobuzzi Jr., Ph.D. (the “Executive”). Recitals . WHEREAS, the Company desires to employ the Executive as a full-time employee …

Category: Contact NumberShow more

Diffusion Pharmaceuticals Issues Letter to Shareholders

Just Now Benzinga.com Show details

Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body's ability …

Category: Contact NumberShow more

10 Biotech Penny Stocks to Buy Now Insider Monkey

8 hours ago Insidermonkey.com Show details

Number of Hedge Fund Holders: 2 Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) is a biopharma firm that focuses on the development of novel therapies for enhanced delivery of oxygen through the body.

Category: Tech SupportShow more

Evaluation of trans sodium crocetinate on safety and

3 hours ago Ncbi.nlm.nih.gov Show details

The number of placebo patients showing serious adverse events was 2/8 (25%) versus 3/40 (7.5%) of the TSC-treated patients. Patients showing adverse events were 7/8 (87.5%) for the placebo group and 24/40 (60%) for the TSC-treated patients. Thus, TSC appears to …

Category: Contact NumberShow more

Companies with 'D' EIN, Address and Contact Page 6

Just Now Eintaxid.com Show details

516-900-3799EIN Number: 33-1223037 Address: 6160 Plumas Street, Suite 100, Reno, Nevada Doing Business As: Diego Pellicer Worldwide Inc Phone: 516-900-3799

Category: Contact SupportShow more

A GenomicPathologic Annotated Risk Model to Predict

3 hours ago Ncbi.nlm.nih.gov Show details

Limitations of our study include a limited number of recurrence events, with a median follow-up of 2.5 years; however, 80% of recurrences in patients with completely resected early-stage LUAD occur within 2 years. 1,3 In addition, we were able to identify patients with stages II and III cancer with low recurrence risk as well as those with high

Category: Contact NumberShow more

3M™ SecureFit™ Hard Hat H700 Series 3M United States

4 hours ago 3m.com Show details

Help give your workers an excellent blend of comfort, style and safety with 3M™ SecureFit™ Hard Hat Series. Available in cap style or full brim models, the suspension system incorporates patented Pressure Diffusion Technology and sits low on the head for greater comfort and security. Select models feature a proprietary indicator that lets wearer know when to replace …

Category: Contact NumberShow more

RestorGenex PE Ratio 20072021 DFFN MacroTrends

7 hours ago Macrotrends.net Show details

Current and historical p/e ratio for RestorGenex (DFFN) from 2007 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Category: Contact NumberShow more

Diffusion Pharmaceuticals : HC Wainwright BioConnect

Just Now Marketscreener.com Show details

Diffusion Pharmaceuticals Inc. published this content on 10 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 January 2022 16:54:04 UTC.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is diffdiffusion pharmaceuticals?

Diffusion Pharmaceuticals Inc. is a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most.

Who holds Diffusion Pharmaceuticals'stock?

Only 1.40% of the stock of Diffusion Pharmaceuticals is held by insiders. Only 9.79% of the stock of Diffusion Pharmaceuticals is held by institutions. Earnings for Diffusion Pharmaceuticals are expected to grow in the coming year, from ($0.22) to ($0.17) per share.

Should you hold Diffusion Pharmaceuticals (dffn) stock?

The consensus among Wall Street research analysts is that investors should "hold" Diffusion Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DFFN, but not buy additional shares or sell existing shares.

When is Diffusion Pharmaceuticals expected to release its next quarterly earnings?

Diffusion Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, March 16th 2022. View our earnings forecast for Diffusion Pharmaceuticals.

Popular Brands

Daikin
Denso
Demant
Dsv
Dlf
Dbs
Dsm
Dana